Kenvue (NYSE:KVUE – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.27 by $0.01, Briefing.com reports. Kenvue had a net margin of 7.23% and a return on equity of 21.80%. The business had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same quarter in the previous year, the business posted $0.31 EPS. The company’s quarterly revenue was down .4% compared to the same quarter last year. Kenvue updated its FY 2024 guidance to 1.100-1.200 EPS and its FY24 guidance to $1.10-1.20 EPS.
Kenvue Stock Up 3.1 %
NYSE:KVUE opened at $23.68 on Friday. The company has a current ratio of 0.99, a quick ratio of 0.68 and a debt-to-equity ratio of 0.69. Kenvue has a twelve month low of $17.67 and a twelve month high of $23.72. The company has a market cap of $45.35 billion, a PE ratio of 40.83, a P/E/G ratio of 2.94 and a beta of 1.36. The company’s 50 day moving average is $22.65 and its two-hundred day moving average is $20.54.
Kenvue Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th will be given a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 3.46%. The ex-dividend date is Wednesday, November 13th. Kenvue’s payout ratio is currently 141.38%.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on KVUE
About Kenvue
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Featured Articles
- Five stocks we like better than Kenvue
- How to Invest in Insurance Companies: A GuideĀ
- California Resources Stock Could Be a Huge Long-Term Winner
- What is the Euro STOXX 50 Index?
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- What is MarketRankā¢? How to Use it
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.